AI pharma investment reached $15B in 2025. See why this rapid growth matters for new drug development and what to watch next.
Charles Walsh
·
How can startups thrive in 2026's tough economy? Learn 5 strategies for success, from 12-month capital to agile MVPs.
·
2026's inverted yield curve impacts startups. Learn how to conserve cash, attract investors, and find M&A opportunities in a tough market.
·
Founders: structuring an ESOP? Learn how 409A valuations and ISOs vs. NSOs impact equity, taxes, and talent. Avoid common pitfalls.
·
Global trade faces volatility. Can Geopolitical AI help? See how companies cut logistics disruptions by 15-20% and identify risks like Red Sea challenges.
·
·
7 min read
Small pharma's rise (70% of new drugs) creates skill gaps. See what talent is needed and how VC funding ($60B in 2025) fuels new roles.
·
·
9 min read
Will new pharma startups bring down drug prices in 2026? Learn how companies like Valera Health aim to reduce costs for consumers.
·
·
5 min read
B2B product leadership is changing. See how leading firms adapt strategies for 2026 to boost market share and retention, with 72% citing product experience.
·
·
5 min read
CRISPR gene-editing in agriculture is set for $50B+ investment by 2030. Learn why it matters for crops, food, and future growth opportunities.
·
·
8 min read
How tech rebuilds war-torn regions. See how digital aid, mobile payments, and AI help restore stability and peace by 2027.
·
·
7 min read
